• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Cytosorbents Corp (CTSO)

Common Shares
Sell: $0.9505|Buy: $1.02|Change: 0 (0%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Address

7 Deer Park Drive
Suite K
Monmouth Junction
NJ
USA
08852

Telephone

+1 732 329-8885

Website

https://www.cytosorbents.com

Sector 

Healthcare

Forecast key dates

NameKey Date
CytoSorbents Corp First Quarter Earnings Conference Call for 20262026-05-14T16:30:00
CytoSorbents Corp First Quarter Earnings Results for 20262026-05-14T00:00:00
CytoSorbents Corp Fourth Quarter Earnings Conference Call for 20252026-03-31T16:30:00
CytoSorbents Corp Fourth Quarter Earnings Results for 20252026-03-31T00:00:00
CytoSorbents Corp Annual Report for 20252026-03-31T00:00:00
CytoSorbents Corp Third Quarter Earnings Conference Call for 20252025-11-07T16:30:00
CytoSorbents Corp Third Quarter Earnings Results for 20252025-11-07T00:00:00
CytoSorbents Corp Second Quarter Earnings Conference Call for 20252025-08-13T16:30:00
CytoSorbents Corp Second Quarter Earnings Results for 20252025-08-13T00:00:00
CytoSorbents Corp Annual General Meeting for 20252025-06-06T10:00:00
CytoSorbents Corp First Quarter Earnings Conference Call for 20252025-05-14T16:30:00
CytoSorbents Corp First Quarter Earnings Results for 20252025-05-14T00:00:00

Previous key dates

NameKey Date
CytoSorbents Corp First Quarter Earnings Conference Call for 20252025-05-14T16:30:00
CytoSorbents Corp First Quarter Earnings Results for 20252025-05-14T00:00:00
CytoSorbents Corp Fourth Quarter Earnings Conference Call for 20242025-03-31T16:30:00
CytoSorbents Corp Fourth Quarter Earnings Result for 20242025-03-31T00:00:00
CytoSorbents Corp Annual Report for 20242025-03-31T00:00:00
CytoSorbents Corp Third Quarter Earnings Conference Call for 20242024-11-07T16:30:00
CytoSorbents Corp Third Quarter Earnings Result for 20242024-11-07T00:00:00
H.C. Wainwright 26th Annual Global Investment Conference2024-09-09T07:00:00
CytoSorbents Corp Second Quarter Earnings Conference Call for 20242024-08-13T16:30:00
CytoSorbents Corp Second Quarter Earnings Result for 20242024-08-13T00:00:00
CytoSorbents Corp Annual General Meeting for 20242024-06-06T10:00:00
CytoSorbents Corp First Quarter Earnings Conference Call for 20242024-05-09T16:30:00
CytoSorbents Corp First Quarter Earnings Result for 20242024-05-09T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.